Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
Julie Rayes, Associate Professor at University of Birmingham, shared a post on LinkedIn about a recent article she and her colleague co-authored, adding:
“Delighted to share a News and Views I co-wrote with Jagadeesh Bayry in Nature Reviews Cardiology, commenting on a seminal NEJM study arising from an international collaboration solving the mystery of vaccine-induced immune thrombocytopenia and thrombosis (VITT): Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.”
Title: Solving the mystery of vaccine-induced immune thrombocytopenia and thrombosis
Authors: Julie Rayes and Jagadeesh Bayry
Read the Full Article on Nature Reviews Cardiology

Title: Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Authors: Jing Jing Wang, Linda Schönborn, Theodore E Warkentin, Luisa Müller, Thomas Thiele, Lena Ulm, Uwe Völker, Sabine Ameling, Sören Franzenburg, Lars Kaderali, Ana Tzvetkova, Alex Colella, Tim Chataway, Chee Wee Tan, Bridie Armour, Alexander Troelnikov, Lucy Rutten, James McCluskey, Roland Zahn, Tom P Gordon, Andreas Greinacher
Read the Full Article on NEJM

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines